Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-PROT-30

ABSTRACT: A Multiregional Proteomic Survey of the Postnatal Human Brain

TISSUE(S): Cerebellum, Striatum, Amygdala, Primary Visual Cortex, Dorsolateral Prefrontal Cortex, Hippocampus, Medial Dorsal Nucleus Of Thalamus

PROVIDER: E-PROT-30 | ExpressionAtlas | 2021-05-25

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-PROT-30-analysis-methods.tsv	Tabular
	E-PROT-30-configuration.xml	Xml
	E-PROT-30-factors.xml	Xml
	E-PROT-30-zoomifications-log.tsv	Tabular
	E-PROT-30.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 11

Similar Datasets

E-PROT-31

Project description:Proteomic Atlas of the human brain in Alzheimer's disease

2021-05-25 | E-PROT-31 | ExpressionAtlas

E-PROT-61

Project description:Proteomic Atlas of the Human Brain in Alzheimer's Disease

2021-05-25 | E-PROT-61 | ExpressionAtlas

E-PROT-36

Project description:Proteomic Investigations of Autism Brain

2022-01-06 | E-PROT-36 | ExpressionAtlas

CEGS Proteomics - A multiregional proteomic survey of the postnatal human brain

Project description:Here we exploit label-free quantitative tandem mass-spectrometry proteomics to create the first in-depth quantitative proteomic survey of regions of the postnatal human brain. We adopted a dual approach to analysing these human brain samples similar to that of a recent high-quality study of the mouse brain proteome by Sharma et al, 2015. First was the discovery phase, designed to create a highly sensitive, heavily fractionated spectral library for each adult brain region. Then, to produce a quantitative run for each adult and postnatal development sample, single shot LC-MS/MS runs were used to accurately quantify proteins based on detected precursor peptide ion mass.

2018-01-09 | PXD005445 | Pride

Gene and miRNA expression data from primate postnatal brain in prefrontal cortex: time course

Project description:This SuperSeries is composed of the following subset Series: GSE17757: Gene expression data from primate postnatal brain in prefrontal cortex: time course GSE18012: miRNA expression data from human postnatal brain in prefrontal cortex: time course GSE18013: miRNA expression data from rhesus macaque postnatal brain in prefrontal cortex: time course Refer to individual Series

2010-06-09 | E-GEOD-18069 | biostudies-arrayexpress

E-PROT-33

Project description:Proteomic analysis of human anterior pituitary gland

2022-01-06 | E-PROT-33 | ExpressionAtlas

E-PROT-63

Project description:Proteomic evaluation of decellularized human umbilical artery

2022-01-10 | E-PROT-63 | ExpressionAtlas

A heterodimer of α and β hemoglobin chains functions as an innate anticancer agent

Project description:Metastatic (as well as tumor) microenvironments contain both cancer-promoting as well as cancer restraining factors. The balance between these opposing forces determines the fate of cancer cells that disseminate to secondary organ sites. In search for microenvironmental drivers or inhibitors of metastasis, we identified, in a previous study, the beta subunit of hemoglobin (HBB) as a lung-derived antimetastatic factor. In the present study, exploring mechanisms leading to melanoma brain metastasis, we discovered that brain-derived factors restrain proliferation and induce apoptosis and necrosis of brain-metastasizing melanoma cells. Employing various purification procedures, we identified a heterodimer composed of hemoglobin alpha and beta chains that performs these anti-metastatic functions. Neither the alpha nor the beta subunit alone were inhibitory. An alpha/beta chain dimer chemically purified from human hemoglobin inhibited the cell viability of primary melanomas, melanoma brain metastasis (MBM), and breast cancer cell lines. The dimer-induced DNA damage, cell cycle arrest at the SubG1 phase, apoptosis, and significant necrosis in four MBM cell lines. Proteomic analysis of dimer-treated MBM cells revealed that the dimer downregulates the expression of BRD4, GAB2, and IRS2 proteins playing crucial roles in cancer cell sustainability and progression.

2023-03-08 | GSE225459 | GEO

E-PROT-32

Project description:Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease

2021-05-25 | E-PROT-32 | ExpressionAtlas

Identification of an effective early signaling signature during neo-vasculogenesis in vivo by ex vivo proteomic profiling

Project description:Therapeutic neo-vasculogenesis in vivo can be achieved by the co-transplantation of human endothelial colony-forming progenitor cells (ECFCs) with mesenchymal stem/progenitor cells (MSPCs).The underlying mechanism is not completely understood thus hampering the development of novel stem cell therapies.We hypothesized that proteomic profiling could be used to retrieve the in vivo signaling signature during the initial phase of human neo-vasculogenesis. ECFCs and MSPCs were therefore either transplanted alone or co-transplanted subcutaneously into immune deficient mice. Early cell signaling, occurring within the first 24 hours in vivo, was analyzed using antibody microarray proteomic profiling.Vessel formation and persistence were verified in parallel transplants for up to 24 weeks. Proteomic analysis revealed significant alteration of regulatory components including caspases, calcium/calmodulin-dependent protein kinase, DNA protein kinase,human ErbB2 receptor-tyrosine kinase as well as mitogen-activated protein kinases.Therapeutic candidate caspase-4 was selected from array results for targeting vascular network formation in vitro as well as modulating therapeutic vasculogenesis in vivo. As a proof-of-principle, caspase-4 and general caspase-blocking led to diminished endothelial network formation in vitro and significantly decreased vasculogenesis in vivo. Proteomic profiling ex vivo thus unraveled a signaling signature which can be targeted to modulate neo-vasculogenesis in vivo.

2013-04-09 | GSE45896 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data